Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest update is out from Beijing Tong Ren Tang Chinese Medicine Co ( (HK:3613) ).
Beijing Tong Ren Tang Chinese Medicine Co. announced that its board of directors will meet on March 28, 2025, to approve the annual results for 2024 and consider the payment of a final dividend. This meeting could impact the company’s financial strategy and stakeholder returns, reflecting its ongoing commitment to transparency and shareholder value.
More about Beijing Tong Ren Tang Chinese Medicine Co
Beijing Tong Ren Tang Chinese Medicine Co. is a company incorporated in Hong Kong, operating in the traditional Chinese medicine industry. It focuses on the production and distribution of Chinese medicinal products.
YTD Price Performance: -0.31%
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $910.3M
For a thorough assessment of 3613 stock, go to TipRanks’ Stock Analysis page.